Warning letter
Madison One Acme Inc: warning letter of Jul 26, 2017
FDA warning letter UCM588792 · Los Angeles District Office
Key facts
| Reference number | UCM588792 |
|---|---|
| Company | Madison One Acme Inc |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | Jul 26, 2017 |
| Posted date | Jul 26, 2017 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| CFR sections cited | 111.55, 111.105, 111.70(f), 111.127(h), 111.140(b)(2), 101.36(b)(2)(iii), 101.36(e)(6), 101.9(c), 201.5 |
| Country | 3 |
| Inspection city | Los Angeles |
| Inspection ZIP | 90012 |
| Inspection start date | Feb 28, 2017 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: